[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Nowwell AS\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":58},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":57},"100653097","effectiveness-of-the-nowcath-foley-in-reducing-catheter-associated-utis-and-blockages-in-long-term-indwelling-catheter-users-reduce-100653097",false,"NCT07782762","Effectiveness of the NowCath Foley in Reducing Catheter-Associated UTIs and Blockages in Long-Term Indwelling Catheter Users (REDUCE)","A Randomized, Blinded, Controlled Crossover Trial Evaluating Effectiveness of NowCath Foley in Reducing Catheter-Associated Urinary Tract Infections and Blockages in Long-Term Indwelling Catheter Users","REDUCE","Inclusion Criteria:\n\n* Adults aged 18 years or older\n* Indwelling urethral or suprapubic Foley catheter in place for at least 28 days prior to enrolment\n* Expected need for continued indwelling catheterization for at least 6 months\n* No systemic antibiotic treatment for CAUTI within 48 hours prior to enrolment\n* Written informed consent provided by the participant\n* Receiving community nursing care from Ikast-Brande or Holstebro municipalities (or otherwise cared for by their services)\n\nExclusion Criteria:\n\n* Known allergy or hypersensitivity to silicone or glycerin\n* Straight-tip catheterization considered clinically unsuitable\n* Planned continuation of prophylactic antibiotics for frequent CAUTI\n* Ureteric stents in place or planned genito-urinary procedures during the study period\n* Pregnancy, lactation, or planned pregnancy during the study period","ALL","18 Years",{"count":20,"type":21},160,"ESTIMATED","INTERVENTIONAL",[24],"NA","People who rely on long-term indwelling urinary (Foley) catheters often experience recurrent urinary tract infections and catheter blockages that require unscheduled catheter changes, additional antibiotics, and emergency visits. These complications reduce quality of life and increase healthcare use.\n\nThe NowCath Foley is an all-silicone indwelling urinary catheter with two additional drainage eyelets positioned below the retention balloon. A thin silicone skirt covers the eyelets to reduce suction against the bladder wall. The design is intended to improve bladder emptying and reduce mucosal contact, which may in turn lower the rate of catheter-associated urinary tract infections (CAUTIs) and blockages compared with a conventional all-silicone Foley catheter.\n\nThe REDUCE study is a multi-centre, randomized, blinded, controlled crossover clinical investigation conducted in Denmark. The primary goal is to determine whether the NowCath Foley catheter can reduce incidence of CAUTI over 12 weeks compared to a conventional long-term indwelling Foley catheter in an adult population using indwelling urethral or suprapubic Foley catheters . The participants (n=160) are cared for and enrolled by community nursing services in the Ikast-Brande and Holstebro municipalities in collaboration with the coordinating site at Regional Hospital Gødstrup. Each participant will use both the NowCath Foley and a conventional all-silicone Foley catheter (Rüsch Brillant, Teleflex Medical) in a randomized sequence, for 12 weeks each (24 weeks total).\n\nThe primary outcome is the rate of catheter changes per 100 catheter days. Secondary outcomes include CAUTI incidence, blockage incidence, residual urine volume, encrustation, antibiotic use, quality of life, patient comfort, safety, and cost-effectiveness.\n\nDuring phase 1, participants will be randomised to either NowCath or the conventional Foley catheter and will be seen at weeks 0 and 12. At week 12 participants will be crossed-over to phase 2, where they will receive the other catheter not allocated in phase 1 and will be seen at weeks 12 and 24. As the participants would default to the comparator catheter as part of standard of care, the wash-out period is minimal.",[27,28,29,30],"Urinary Catheters","Urinary Catheterization","Catheter-Related Infections","Catheter Associated Urinary Tract Infection",[32,33,34,35,36,37,38,39,40,41,42,43,44],"Urinary Catheter","Indwelling catheter","CAUTI","catheter associated urinary tract infection","catheter encrustation","foley catheter","catheter blockage","community nursing","crossover trial","silicone urinary catheter","medical device","urology","long-term indwelling catheterization","RECRUITING","2026-09-18",{"date":48,"type":49},"2026-09-23","ACTUAL",{"date":51,"type":49},"2026-08-10",{"date":53,"type":21},"2027-12-10",{"name":55,"class":56},"Nowwell AS","INDUSTRY",3,""]